I think I’m officially a long-term metastatic breast cancer survivor…

What price survival?  I think I’m officially a long-term metastatic breast cancer survivor. I mean I have just passed five years since diagnosis and when I looked up the average

METUPUK are delighted by the Scottish Medicines Consortium (SMC) acceptance of Enhertu (trastuzumab deruxtecan) for routine use on the NHS.

METUPUK are delighted by the Scottish Medicines Consortium (SMC) acceptance of Enhertu (trastuzumab deruxtecan) for routine use on the NHS. The Scottish Medicines Consortium (SMC) has accepted: Trastuzumab deruxtecan (Enhertu)